Zacks Analyst Blog Highlights: Advance Auto Parts and Sciele Pharma

Business Wire, July 3, 2006

CHICAGO -- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day, the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Advance Auto Parts (NYSE: AAP) and Sciele Pharma, Inc. (Nasdaq: SCRX).

See the latest posts to the Analyst Blog by visiting: http://at.zacks.com/?id=2673

Here are highlights from Friday's Analyst Blog:

AAP Reduces Its Guidance

Advance Auto Parts (NYSE: AAP) reduced its guidance for the second quarter to 57-59 cents per share. This is due to a drop in same store growth from 4-5% to 1-2%. This is due to a slowdown in demand from the low-end consumer, who is pinched by higher gas prices and higher interest rates. The stock is a Hold with a target of $30.

Need Visibility on SCRX

Sciele Pharma, Inc. (Nasdaq: SCRX) is a specialty pharmaceutical company engaged in the sale of prescription products for the treatment of cardiovascular, metabolic, obstetrical and gynecological, and pediatric and gastroenterological conditions and disorders. The company's broad focus and deep product pipeline offers substantial growth opportunities over the next several years.

Yet, competition is high for almost all the key products and we regard the successful navigation of these issues as risky. The stock offers a compelling valuation but we currently rate the shares only a hold based on limited visibility.

See the latest posts to the Analyst Blog by visiting http://at.zacks.com/?id=2645

About Zacks Equity Research

Zacks Equity Research provides the best of quantitative and qualitative analysis to help investors know what stocks to buy and which to sell for the long-term.

Continuous coverage is provided for a universe of 1,150 publicly traded stocks. Our analysts are organized by industry which gives them keen insights to developments that affect company profits and stock performance. Recommendations and target prices are six-month time horizons.

Zacks "Profit from the Pros" e-mail newsletter provides highlights of the latest analysis from Zacks Equity Research. Subscribe to this free newsletter today by visiting http://at.zacks.com/?id=2674.

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros.